As a drug delivery system, drug-loaded ferritin nanoparticles have shown higher efficacy in targeting cancer cells compared to free drugs [174], especially since TfR1, which binds H-ferritin, is highly expressed on the surface of many cancer cells. This evidence concerns the gene TFRC and cancer.